Literature DB >> 655919

Retinitis pigmentosa. Genetic percentages.

G A Fishman.   

Abstract

A total of 173 patients, from 124 families, with retinitis pigmentosa were evaluated for the presence of various forms of genetic transmission. Of the 124 pedigrees, it was evident that some form of genetic transmission had occurred in 59 (48%). In 65 families (52%), the proband was the only known affected family member (isolated case). In those families with know genetic transmission, 17% (10 patients) were X-linked recessive, 39% (23 patients) were either probable or certain autosomal dominant, 41% (24 patients) were certain or probable autosomal recessive, and 3% (2 patients) were of a genetic type that could not be determined with certainty. These findings are, to my knowledge, the first published series from the United States to indicate that the X-linked recessive form of retinitis pigmentosa is a more prevalent genetic trait than has been emphasized previously.

Entities:  

Mesh:

Year:  1978        PMID: 655919     DOI: 10.1001/archopht.1978.03910050428005

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  42 in total

1.  RPGR-ORF15, which is mutated in retinitis pigmentosa, associates with SMC1, SMC3, and microtubule transport proteins.

Authors:  Hemant Khanna; Toby W Hurd; Concepcion Lillo; Xinhua Shu; Sunil K Parapuram; Shirley He; Masayuki Akimoto; Alan F Wright; Ben Margolis; David S Williams; Anand Swaroop
Journal:  J Biol Chem       Date:  2005-07-25       Impact factor: 5.157

2.  Optical coherence tomography and electro-oculogram abnormalities in X-linked retinitis pigmentosa.

Authors:  Enzo Maria Vingolo; Maria Luisa Livani; D Domanico; Regina H F Mendonça; Eduardo Rispoli
Journal:  Doc Ophthalmol       Date:  2006-09-06       Impact factor: 2.379

3.  Localization of the gene for X-linked recessive type of retinitis pigmentosa (XLRP) to Xp21 by linkage analysis.

Authors:  M A Musarella; A Burghes; L Anson-Cartwright; M M Mahtani; R Argonza; L C Tsui; R Worton
Journal:  Am J Hum Genet       Date:  1988-10       Impact factor: 11.025

4.  Difficulty in performing everyday activities in patients with juvenile macular dystrophies: comparison with patients with retinitis pigmentosa.

Authors:  J P Szlyk; G A Fishman; S Grover; B I Revelins; D J Derlacki
Journal:  Br J Ophthalmol       Date:  1998-12       Impact factor: 4.638

5.  RP2 phenotype and pathogenetic correlations in X-linked retinitis pigmentosa.

Authors:  Thiran Jayasundera; Kari E H Branham; Mohammad Othman; William R Rhoades; Athanasios J Karoukis; Hemant Khanna; Anand Swaroop; John R Heckenlively
Journal:  Arch Ophthalmol       Date:  2010-07

6.  Hereditary and clinical features of retinitis pigmentosa in Koreans.

Authors:  Sun Ho Lee; Hyeong Gon Yu; Jong Mo Seo; Sang Woong Moon; Jun Woong Moon; Sang Jin Kim; Hum Chung
Journal:  J Korean Med Sci       Date:  2010-05-24       Impact factor: 2.153

7.  Interaction of retinitis pigmentosa GTPase regulator (RPGR) with RAB8A GTPase: implications for cilia dysfunction and photoreceptor degeneration.

Authors:  Carlos A Murga-Zamalloa; Stephen J Atkins; Johan Peranen; Anand Swaroop; Hemant Khanna
Journal:  Hum Mol Genet       Date:  2010-07-14       Impact factor: 6.150

8.  A novel mutation in retinitis pigmentosa GTPase regulator gene with a distinctive retinitis pigmentosa phenotype in a Chinese family.

Authors:  Xunlun Sheng; Zili Li; Xinfang Zhang; Jing Wang; Hongwang Ren; Yanbo Sun; Ruihua Meng; Weining Rong; Wenjuan Zhuang
Journal:  Mol Vis       Date:  2010-08-15       Impact factor: 2.367

9.  Cellular imaging demonstrates genetic mosaicism in heterozygous carriers of an X-linked ciliopathy gene.

Authors:  Sung Pyo Park; In Hwan Hong; Stephen H Tsang; Stanley Chang
Journal:  Eur J Hum Genet       Date:  2013-02-27       Impact factor: 4.246

10.  Mutations in RPGR and RP2 account for 15% of males with simplex retinal degenerative disease.

Authors:  Kari Branham; Mohammad Othman; Matthew Brumm; Athanasios J Karoukis; Pelin Atmaca-Sonmez; Beverly M Yashar; Sharon B Schwartz; Niamh B Stover; Karmen Trzupek; Dianna Wheaton; Barbara Jennings; Maria Laura Ciccarelli; K Thiran Jayasundera; Richard A Lewis; David Birch; Jean Bennett; Paul A Sieving; Sten Andreasson; Jacque L Duncan; Gerald A Fishman; Alessandro Iannaccone; Richard G Weleber; Samuel G Jacobson; John R Heckenlively; Anand Swaroop
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-12-13       Impact factor: 4.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.